von Dr. Bernd Fabry | Mai 30, 2021 | Allgemein
With more than 500 million sold over the past three decades and a market share of over 40 percent (2017), the chocolate bunny in gold foil, red bow and bell is the clear market leader. But there can be no talk of post-Easter peace. Bad karma for gold bunnies in the...
von Dr. Bernd Fabry | Mai 8, 2021 | Allgemein
In recent days, politicians and the media have been discussing the possible suspension of patent protection for Covid-19 drugs. However, the reporting suffers from the fact that the actors have little idea of the matter. Is time for a closer look. Can the WHO suspend...
von Dr. Bernd Fabry | Mrz 6, 2021 | Allgemein
Dubious business model Patent trolls are well-funded companies that have no research and development of their own and whose business model is to buy up patents at low prices and then try to enforce them against alleged (or actual) infringers. Last year, for example,...
von Dr. Bernd Fabry | Dez 31, 2020 | Allgemein
Molnupiravir (development codes MK-4482 and EIDD-2801) is an experimental antiviral drug originally developed by Emory University for the treatment of influenza. It is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine and exerts its antiviral effect...
von Dr. Bernd Fabry | Dez 21, 2020 | Allgemein
The patent dispute between Nokia and Daimler concerning alleged infringement of various mobile communications patents will now step to the ECJ. On Thursday December 17, 2020 the Düsseldorf Regional Court (LG) announced submitting several questions to the ECJ...
